Psychedelic Research and Clinical Trials

Explore some of the highest quality research on psychedelics and mental health.

Depression

Addiction
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Depression
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Depression

Psilocybin To Treat Treatment Resistant Depression

Read more →
Depression
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Anxiety, Depression
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Anxiety, Depression

Psilocybin Study Shows Decrease In Depression & Anxiety

Read more →
Anxiety, Depression
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
Trauma, Depression
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
Trauma, Depression

Ketamine Infusions To Treat Comorbid PTSD and TRD

Read more →
Trauma, Depression
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Depression, Anxiety
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Depression, Anxiety

Psilocybin To Treat Anxiety & Depression In Patients With Cancer

Read more →
Depression, Anxiety
Single-Dose Psilocybin Treatment for Major Depressive Disorder
Depression
Single-Dose Psilocybin Treatment for Major Depressive Disorder
Depression

Psilocybin To Treat Major Depressive Disorder

Read more →
Depression
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomized clinical trial
Depression
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomized clinical trial
Depression

Psilocybin To Treat Major Depressive Disorder (Placebo-Controlled, Double Blind)

Read more →
Depression

Trauma, PTSD, cPTSD

Addiction
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
Trauma
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
Trauma

Cannabis To Treat PTSD & Improve Well-Being

Read more →
Trauma
The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
Trauma
The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
Trauma

Cannabis To Treat PTSD & Nightmare Symptoms

Read more →
Trauma
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers
Trauma
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers
Trauma

MDMA To Treat PTSD In Military Vets, Firefighters, & Police Officers

Read more →
Trauma
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder
Trauma
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder
Trauma

MDMA To Treat Chronic & Treatment Resistant PTSD

Read more →
Trauma
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy
Trauma
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy
Trauma

MDMA To Treat PTSD, Long-Term Outcomes

Read more →
Trauma
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
Trauma, Depression
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
Trauma, Depression

Ketamine Infusions To Treat Comorbid PTSD and TRD

Read more →
Trauma, Depression

Addiction, Drinking, & Substance Use

Addiction
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Addiction
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Addiction

Psilocybin To Treat Alcohol Use Disorder

Read more →
Addiction
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Addiction
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Addiction

Ibogaine To Treat Opioid Dependence

Read more →
Addiction
Long-term follow-up of psilocybin-facilitated smoking cessation
Addiction
Long-term follow-up of psilocybin-facilitated smoking cessation
Addiction

Psilocybin To Treat Tobacco Smoking

Read more →
Addiction

Anxiety

Addiction
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Anxiety, Depression
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Anxiety, Depression

Psilocybin Study Shows Decrease In Depression & Anxiety

Read more →
Anxiety, Depression
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Depression, Anxiety
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Depression, Anxiety

Psilocybin To Treat Anxiety & Depression In Patients With Cancer

Read more →
Depression, Anxiety